Stremmel Christian, Sienel Wulf, Eggeling Stephan, Passlick Bernward, Slavin Anthony
Department of Thoracic Surgery, Albert-Ludwigs-University Freiburg, Hugstetterstrasse 55, 79106 Freiburg, Germany.
Eur J Cardiothorac Surg. 2006 Aug;30(2):362-9. doi: 10.1016/j.ejcts.2006.04.014. Epub 2006 Jul 7.
For a successful immune response, migration of lymphocytes to lymphoid organs and other tissues is a key step, as the initial recognition of foreign antigens and activation of lymphocytes takes place in these organs. CD62L is a homing receptor that mediates entry of naïve T cells to peripheral lymph nodes. Maybe the preventing of T cell homing will change the immune response against allogeneic tissue and suppress rejection.
We treated different mouse strains with pertussis toxin to manipulate T cell homing and measured the rejection of allografts in terms of allogeneic tumor cells. We transferred pertussis toxin treated or nontreated transgenic T cells into BALB/c wild type mice. The transgenic T cells could be followed ex vivo by specific antibodies. Cytokine production from purified (1x10(5)/ml) T cells after different stimulations in vitro and expression of surface markers on T cells following pertussis toxin treatment by FACS analysis were performed.
Pertussis toxin-treated C57BL/6 mice with the MHC class I molecule H-2K(b) could not reject allogeneic tumor cells R1.1, which expressed the MHC class I molecule H-2K(k) and were killed by these cells. This allograft survival could be demonstrated for various allogeneic cells in different mouse strains with different MHC class I expression and emphasizes the general mechanism in these studies. In vivo CD62L expression on T cells was down-regulated by pertussis toxin in normal mice and transgenic mice that produce only one specific T cell, and after the pertussis toxin treatment the mice showed 4-5 times larger spleens compared to untreated mice. In transfer experiments, we demonstrated that CD62L low transgenic T cells could not home to lymph nodes. Furthermore, spleen cells from pertussis toxin-treated mice produced high amounts of the Th-2 cytokine interleukin 4 after stimulation in primary culture.
Our data suggest that the inhibition of T cell homing changes the immune response. Prevention of homing of T cells in combination with the induction of a Th-2 response is a mechanism to prevent specific acute rejection of allogeneic tissue.
对于成功的免疫反应而言,淋巴细胞向淋巴器官和其他组织的迁移是关键步骤,因为对外来抗原的初始识别和淋巴细胞的激活在这些器官中发生。CD62L是一种归巢受体,介导幼稚T细胞进入外周淋巴结。也许阻止T细胞归巢会改变针对同种异体组织的免疫反应并抑制排斥反应。
我们用百日咳毒素处理不同的小鼠品系以操控T细胞归巢,并根据同种异体肿瘤细胞来测量同种异体移植物的排斥反应。我们将经百日咳毒素处理或未处理的转基因T细胞转移到BALB/c野生型小鼠体内。转基因T细胞可以通过特异性抗体在体外进行追踪。通过体外不同刺激后对纯化的(1×10⁵/ml)T细胞进行细胞因子产生检测,以及通过流式细胞术分析百日咳毒素处理后T细胞表面标志物的表达。
用I类主要组织相容性复合体分子H-2K(b)处理的C57BL/6小鼠不能排斥表达I类主要组织相容性复合体分子H-2K(k)的同种异体肿瘤细胞R1.1,且这些细胞会杀死这些小鼠。在不同的小鼠品系中,对于具有不同I类主要组织相容性复合体表达的各种同种异体细胞,均可证明这种同种异体移植物的存活,这强调了这些研究中的一般机制。在正常小鼠和仅产生一种特异性T细胞的转基因小鼠中,百日咳毒素下调了T细胞上的体内CD62L表达,并且在百日咳毒素处理后,小鼠的脾脏比未处理的小鼠大4 - 5倍。在转移实验中,我们证明CD62L低表达的转基因T细胞不能归巢到淋巴结。此外,来自经百日咳毒素处理的小鼠的脾细胞在原代培养刺激后产生大量的Th-2细胞因子白细胞介素4。
我们的数据表明,抑制T细胞归巢会改变免疫反应。阻止T细胞归巢并诱导Th-2反应是防止同种异体组织特异性急性排斥反应的一种机制。